Exposure to perfluoroalkyl substances and longitudinal changes in bone mineral density in adolescents and young adults: A multi-cohort study
- PMID: 38061983
- PMCID: PMC10922273
- DOI: 10.1016/j.envres.2023.117611
Exposure to perfluoroalkyl substances and longitudinal changes in bone mineral density in adolescents and young adults: A multi-cohort study
Abstract
Background: Per- and polyfluoroalkyl substances (PFAS) may impair bone development in adolescence, which impacts life-long bone health. No previous studies have examined prospective associations of individual PFAS and their mixture with bone mineral density (BMD) changes in Hispanic young persons, a population at high risk of osteoporosis in adulthood.
Objectives: To examine associations of individual PFAS and PFAS mixtures with longitudinal changes in BMD in an adolescent Hispanic cohort and examine generalizability of findings in a mixed-ethnicity young adult cohort (58.4% Hispanic).
Methods: Overweight/obese adolescents from the Study of Latino Adolescents at Risk of Type 2 Diabetes (SOLAR; n = 304; mean follow-up = 1.4 years) and young adults from the Southern California Children's Health Study (CHS; n = 137; mean follow-up = 4.1 years) were included in this study. Plasma PFAS were measured at baseline and dual x-ray absorptiometry scans were performed at baseline and follow-up to measure BMD. We estimated longitudinal associations between BMD and five PFAS via separate covariate-adjusted linear mixed effects models, and between BMD and the PFAS mixture via quantile g-computation.
Results: In SOLAR adolescents, baseline plasma perfluorooctanesulfonic acid (PFOS) was associated with longitudinal changes in BMD. Each doubling of PFOS was associated with an average -0.003 g/cm2 difference in change in trunk BMD per year over follow-up (95% CI: -0.005, -0.0002). Associations with PFOS persisted in CHS young adults, where each doubling of plasma PFOS was associated with an average -0.032 g/cm2 difference in total BMD at baseline (95% CI -0.062, -0.003), though longitudinal associations were non-significant. We did not find associations of other PFAS with BMD; associations of the PFAS mixture with BMD outcomes were primarily negative though non-significant.
Discussion: PFOS exposure was associated with lower BMD in adolescence and young adulthood, important periods for bone development, which may have implications on future bone health and risk of osteoporosis in adulthood.
Keywords: Adolescents; Bone mineral density; Children; Endocrine disruptors; Environmental epidemiology; Perfluoroalkyl substances.
Copyright © 2023 The Authors. Published by Elsevier Inc. All rights reserved.
Conflict of interest statement
Declaration of competing interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.
Figures

References
-
- Agency for Toxic Substances and Disease Registry, 2022. PFAS in the US population [WWW Document]. URL https://www.atsdr.cdc.gov/pfas/health-effects/us-population.html (accessed 10.5.22).
MeSH terms
Substances
Grants and funding
- U2C ES030163/ES/NIEHS NIH HHS/United States
- P50 MD017344/MD/NIMHD NIH HHS/United States
- R21 ES029681/ES/NIEHS NIH HHS/United States
- P01 ES022845/ES/NIEHS NIH HHS/United States
- R01 ES030691/ES/NIEHS NIH HHS/United States
- R01 DK059211/DK/NIDDK NIH HHS/United States
- R21 ES028903/ES/NIEHS NIH HHS/United States
- P01 ES011627/ES/NIEHS NIH HHS/United States
- R00 ES027870/ES/NIEHS NIH HHS/United States
- T32 ES013678/ES/NIEHS NIH HHS/United States
- UG3 OD023318/OD/NIH HHS/United States
- R21 ES031824/ES/NIEHS NIH HHS/United States
- R01 ES029944/ES/NIEHS NIH HHS/United States
- P30 ES007048/ES/NIEHS NIH HHS/United States
- R01 ES029963/ES/NIEHS NIH HHS/United States
- R25 GM143298/GM/NIGMS NIH HHS/United States
- P2C ES033433/ES/NIEHS NIH HHS/United States
- R01 ES032831/ES/NIEHS NIH HHS/United States
- P30 ES023515/ES/NIEHS NIH HHS/United States
- R01 ES032189/ES/NIEHS NIH HHS/United States
- U2C ES030859/ES/NIEHS NIH HHS/United States
- R01 ES030364/ES/NIEHS NIH HHS/United States
- P30 ES019776/ES/NIEHS NIH HHS/United States
- R21 ES035148/ES/NIEHS NIH HHS/United States
- R24 ES029490/ES/NIEHS NIH HHS/United States
- P01 CA196569/CA/NCI NIH HHS/United States
- R01 ES033688/ES/NIEHS NIH HHS/United States
- R00 ES027853/ES/NIEHS NIH HHS/United States
LinkOut - more resources
Full Text Sources
Medical